These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19645484)

  • 1. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.
    Derudas M; Carta D; Brancale A; Vanpouille C; Lisco A; Margolis L; Balzarini J; McGuigan C
    J Med Chem; 2009 Sep; 52(17):5520-30. PubMed ID: 19645484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.
    Derudas M; Vanpouille C; Carta D; Zicari S; Andrei G; Snoeck R; Brancale A; Margolis L; Balzarini J; McGuigan C
    J Med Chem; 2017 Sep; 60(18):7876-7896. PubMed ID: 28829913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
    Balzarini J; Haller-Meier F; De Clercq E; Meier C
    Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine.
    McGuigan C; Bidois L; Hiouni A; Ballatore C; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2000 Mar; 11(2):111-6. PubMed ID: 10819435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
    Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
    J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
    McGuigan C; Perrone P; Madela K; Neyts J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
    Mehellou Y; Balzarini J; McGuigan C
    Org Biomol Chem; 2009 Jun; 7(12):2548-53. PubMed ID: 19503928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
    Mehellou Y; Balzarini J; McGuigan C
    ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
    Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
    ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
    Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
    Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
    Kandil S; Pannecouque C; Chapman FM; Westwell AD; McGuigan C
    Bioorg Med Chem Lett; 2019 Dec; 29(24):126721. PubMed ID: 31679972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
    Mehellou Y; McGuigan C; Brancale A; Balzarini J
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3666-9. PubMed ID: 17485204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T.
    Knaggs MH; McGuigan C; Harris SA; Heshmati P; Cahard D; Gilbert IH; Balzarini J
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2075-8. PubMed ID: 10999474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
    Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
    Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.
    Easmon J; Heinisch G; Holzer W; Rosenwirth B
    J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
    Vanpouille C; Lisco A; Introini A; Grivel JC; Munawwar A; Merbah M; Schinazi RF; Derudas M; McGuigan C; Balzarini J; Margolis L
    Antimicrob Agents Chemother; 2012 May; 56(5):2604-11. PubMed ID: 22314523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.
    Slusarczyk M; Serpi M; Pertusati F
    Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.
    Siddiqui AQ; McGuigan C; Ballatore C; Zuccotto F; Gilbert IH; De Clercq E; Balzarini J
    J Med Chem; 1999 Oct; 42(20):4122-8. PubMed ID: 10514282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.